Macquarie Group
JANX icon

Macquarie Group’s Janux Therapeutics JANX Stock Holding History

Macquarie Group’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-76,601
Closed -$1.87M – 1182
2025
Q3 		$1.87M Hold
76,601
– – ﹤0.01% 1190
2025
Q2 		$1.77M Hold
76,601
– – ﹤0.01% 1260
2025
Q1 		$2.07M Hold
76,601
– – ﹤0.01% 1213
2024
Q4 		$4.1M Hold
76,601
– – 0.01% 993
2024
Q3 		$3.48M Hold
76,601
– – ﹤0.01% 1057
2024
Q2 		$3.21M Buy
76,601
+16,601
+28% +$779K ﹤0.01% 1089
2024
Q1 		$2.26M Buy
+60,000
New +$1.31M ﹤0.01% 1186

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return